10:52 AM
 | 
Mar 08, 2018
 |  BC Extra  |  Company News

Reed leaving Roche's pRED division

Roche (SIX:ROG; OTCQX:RHHBY) said John Reed, the head of its Pharma Research and Early Development unit, is leaving the company for "personal reasons" and...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >